Fortilab Pharma Industries Private Limited

Founded in 2014 and headquartered in Tamil Nadu, India.

2014 | Coimbatore, Tamil Nadu (India) | Inactive
Last Updated: April 17, 2024

Fortilab Pharma Industries Profile

Key Indicators

  • Authorised Capital ₹ 0.30 M
  • Paid Up Capital ₹ 0.10 M
  • Company Age 11 Year, 6 Days
  • Last Filing with ROC 31 Mar 2020
  • Revenue Growth 34085.03%
  • Profit Growth 127.41%
  • Ebitda 163.29%
  • Net Worth 20.62%
  • Total Assets 261.17%

About Fortilab Pharma Industries

Fortilab Pharma Industries Private Limited (FPIPL) is Strike Off company established on 31 Jan 2014 with its office registered at Coimbatore, Tamil Nadu, India and has been running since 11 Year, 6 Days with a paid up capital of 0.10 M. According to MCA records, 2 Directors are linked to this company as of 17 Apr 2024.

Company Details

  • Location

    Coimbatore, Tamil Nadu, India

  • Telephone

    +91-XXXXXXXXXX

  • Email Address
  • Website

    -

  • Social Media
    -

Corporate Identity Details

  • CIN/LLPIN

    U24230TZ2014PTC020211

  • Company No.

    020211

  • Company Classification

    Private Limited Indian Non-Government Company

  • Incorporation Date

    31 Jan 2014

  • Date of AGM

    28 Dec 2020

  • Date of Balance Sheet

    31 Mar 2020

  • Listing Status

    Unlisted

  • ROC Code

    Roc Coimbatore

Industry

Trading

Who are the key members and board of directors at Fortilab Pharma Industries?

Board Members (2)

Name Designation Appointment Date Status
Sanjay Singh Country flag representing In Director 31-Jan-2014 Current
Sambasivan Viswamohan Country flag representing In Director 31-Jan-2014 Current

Financial Performance of Fortilab Pharma Industries.

Fortilab Pharma Industries Private Limited, for the financial year ended 2017, experienced significant growth in revenue, with a 34085.03% increase. The company also saw a substantial improvement in profitability, with a 127.41% increase in profit. The company's net worth Soared by an impressive increase of 20.62%.

Graph illustrating revenue growth over time
Graph showing profit and loss trends over time
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
34085.03%
Revenue from Operations
34040.46%
Total Assets
261.17%
Profit or Loss
127.41%
Net Worth
20.62%
EBITDA
163.29%

What is the Ownership and Shareholding Structure of Fortilab Pharma Industries?

In 2017, Fortilab Pharma Industries had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Indicator graph

Charges (Loans)

Placeholder for charges-related data

There are no open charges registered against the company as per our records.

How Many Employees Work at Fortilab Pharma Industries?

Unlock and access historical data on people associated with Fortilab Pharma Industries, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Graph showing employee growth trends

Deals i

Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Fortilab Pharma Industries, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Fortilab Pharma Industries's trajectory.

Rating

Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts

Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Latest Updates, News, and FAQs on Fortilab Pharma Industries

Recent activity within the organization

  • Annual General Meeting

    Fortilab Pharma Industries Private Limited last Annual general meeting of members was held on 28 Dec 2020 as per latest MCA records.

    28 Dec 2020

  • Balance Sheet

    Fortilab Pharma Industries Private Limited has filed its annual Financial statements for the year ended 31 Mar 2020 with Roc Coimbatore.

    31 Mar 2020

  • Director Appointment

    Sanjay Kumar Singh was appointed as a Director was appointed as a Director on 31 Jan 2014 & has been associated with this company since 11 years 6 days .

    31 Jan 2014

  • Director Appointment

    Sambasivan Viswamohan was appointed as a Director was appointed as a Director on 31 Jan 2014 & has been associated with this company since 11 years 6 days .

    31 Jan 2014

  • Company Incorporation

    Fortilab Pharma Industries Private Limited was registered on 31 Jan 2014 with Roc Coimbatore & aged 11 years 6 days as per MCA records.

    31 Jan 2014

Frequently asked questions

  • Fortilab Pharma Industries Private Limited was incorporated on 31 Jan 2014.

  • The authorized share capital of Fortilab Pharma Industries Private Limited is ₹ 0.30 M and paid-up capital is ₹ 0.10 M.

  • Currently 2 directors are associated with Fortilab Pharma Industries Private Limited.

    • Sanjay Kumar Singh
    • Sambasivan Viswamohan
  • As per Ministry of Corporate Affairs (Mca), the registered address of Fortilab Pharma Industries Private Limited is 418-419 First Floor, Gandhipuram Street No-6, Coimbatore, Tamil Nadu, India, 641012.

  • The corporate identification number (CIN) of Fortilab Pharma Industries Private Limited is U24230TZ2014PTC020211 and the company number is 020211 as per Ministry of Corporate Affairs (MCA).

  • According to the financial reports for the fiscal year 2017, the revenue trend for Fortilab Pharma Industries Private Limited has risen by 34085.03%.

  • The financial reports for the fiscal year 2017 indicates that The net worth of Fortilab Pharma Industries Private Limited has experienced an upsurge of 20.62%.

  • The most recent Balance Sheet for Fortilab Pharma Industries Private Limited was filed with the ROC on 31 Mar 2020.